Le Lézard
Classified in: Health, Business
Subjects: CON, EXE, PSF

The Drug Enforcement Administration and the Chicago Crime Commission Launch a Provocative New Billboard Campaign with Clear Channel Outdoor in an Effort to Save Chicagoans from Opioid-Related Deaths & Abuse

CHICAGO, Feb. 14, 2019 /PRNewswire/ -- A partnership was announced today among the U.S. Drug Enforcement Administration (DEA), the Chicago Crime Commission, and Clear Channel Outdoor to highlight a public awareness campaign that addresses the prescription opioid, heroin and fentanyl epidemic that is plaguing the city of Chicago, our state, and our nation.  Provocative and informational drug prevention and treatment messaging has already begun to appear on numerous Clear Channel Outdoor digital billboards in Chicagoland.  This 12-month digital campaign will run on up to 15 digital billboards and on 20 Metra in-station digital displays to promote the prevalence and dangers of opioid abuse.

This collaborative effort between DEA, the Chicago Crime Commission, and Clear Channel Outdoor, is estimated to deliver over 150 million impressions over its 12-month span. The goal is to reach those affected throughout all stages of the fight. These messages target all members of the community, from those in need of prevention programs to those who need help for themselves or a loved one.

In 2017, opioid-related overdose deaths in Illinois exceeded 2,200, with around half of those deaths occurring in the Chicagoland area. Fentanyl is the driving force behind the increase in overdose deaths. According to the Cook County Medical Examiner, in 2017 there were 669 fentanyl-related deaths in Cook County. 

In a news conference held earlier today, DEA Chicago's Associate Special Agent in Charge, Robert J. Bell, and representatives from the Chicago Crime Commission, were joined by Amy Voss, a local advocate in the fight against opioids; Douglas O'Brien, Health and Human Services-Regional Director (Region V); and Kim Bradley-Regional President Clear Channel Outdoor (Midwest) to speak with an audience of reporters and supporters to underscore the need for raising awareness of the opioid crisis across the state of Illinois and the country.

"What we want is to motivate parents and caregivers to talk with their children about the dangers of these deadly substances to prevent experimentation and addiction before it starts.  This campaign offers hope for those who are in the grips of dependence - hope for their families ? hope that there is a path to treatment and stability," said DEA's Robert J. Bell

"DEA is very good at identifying and arresting drug traffickers, but law enforcement efforts alone can't solve the problem. This epidemic needs to be attacked from every angle - catch the bad guys, help those who need it and make sure our children, partners, friends, and neighbors never start misusing drugs," said J.R. Davis, President and Chairman of the Chicago Crime Commission.

"Opioid abuse is a national epidemic," said Kim Bradley, Regional President, Clear Channel Outdoor - Midwest.  "We believe the power of out of home media can direct victims and their families to relief or assistance from addiction. Our collaboration with the DEA and the Chicago Crime Commission will drive awareness in our communities of what is now the deadliest drug crisis in American history. We want citizens of Chicago to know that it's never too late to get help."

One of the best ways to put the dealers out of business is to take away their customers.   If we are open and honest about how deadly this crisis is, we are more likely to reach that child, friend, or spouse before they take that first hit, that first pill, that first step to addiction. Today's announcement, and this billboard campaign, will help jump-start that conversation.



SOURCE U.S. Drug Enforcement Administration; Clear Channel Outdoor

These press releases may also interest you

at 05:00
The Right Step names DeLisa Duncan Russell, LSW, LPC-S, as executive director of its Houston addiction treatment center. Russell has a long career working with complex addiction issues within the military, the religious community and in private...

at 04:52
BioInvent International AB's (publ) (OMXS: BINV) partner Oxurion NV has today reported topline data from a Phase lla study evaluating THR-317, a humanized antibody against placental growth factor (PlGF), in combination with anti-VEGF (ranibizumab),...

at 04:00
NanoValent Pharmaceuticals, Inc., a development stage cancer focused pharmaceutical company progressing a new class of therapeutic agents called targeted nanospheres (TNS), today announced the acceptance and formal publication of United States Patent...

at 04:00
STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapeutics modulating RNA epigenetics, today announced that it will be hosting an international conference focused on the emerging field of "RNA epigenetics"....

at 03:15
VANCOUVER, Aug. 20, 2019 /CNW/ - EMPOWER CLINICS INC.  ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., today announced...

at 03:12
Gedeon Richter Plc. ("Richter") today announced that it has launched its biosimilar teriparatide, Terrosa® in Europe. The product is approved in adults for the same indications as Eli Lilly's Forsteo®, i.e. used for the treatment of osteoporosis in...

News published on 14 february 2019 at 17:19 and distributed by: